SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma has informed about the Board of Directors of the Company met on 10 August 2017, has Convened 30th Annual General Meeting of the Company on 22nd September, 2017 at 11.00 AM at ESV Hall, Bharatiya Vidya Bhavan, Race Course Road, Bangalore-560001; and decided to close the Register of Members and Share Transfer Books of the Company from 18th September, 2017 to 22nd September, 2017 for ascertaining the entitlement of dividend recommended by the Board at their meeting held on 30.05.2017 and for the 30th Annual General Meeting of the Company scheduled to be held on 22nd September 2017.

The above information is a part of company’s filings submitted to BSE.

Bal Pharma Share Price

77.19 0.00 (0.00%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1660.25
Dr. Reddys Lab 1219.20
Cipla 1230.95
Zydus Lifesciences 932.05
Lupin 2312.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×